Core Scientific, Inc.
CORZNASDAQTechnology● Active
$28.08
+$0.93(+3.43%)
Market Cap$8.9B
P/E Ratio—
52W High$30.46
52W Low$10.93
Core Scientific, Inc.（CORZ）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CORZ · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.31B | $0.84B | $0.05B | $0.02B | $0.12B |
| Net Receivables | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.90B | $0.90B | $0.10B | $0.09B | $0.76B |
| PP&E Net | $1.40B | $0.67B | $0.59B | $0.71B | $0.60B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $1.06B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Total Assets | $2.35B | $1.60B | $0.71B | $0.81B | $2.44B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.02B | $0.12B | $0.04B | $0.08B |
| Accounts Payable | $0.13B | $0.02B | $0.15B | $0.05B | $0.01B |
| Total Current Liabilities | $0.78B | $0.13B | $0.49B | $0.19B | $0.32B |
| Long-Term Debt | $1.06B | $1.07B | $0.68B | $0.00B | $0.65B |
| Total Liabilities | $3.31B | $2.42B | $1.31B | $1.22B | $1.10B |
| Stockholders Equity | |||||
| Retained Earnings | ($4.15B) | ($3.74B) | ($2.42B) | ($2.17B) | ($0.03B) |
| Total Stockholders Equity | ($0.96B) | ($0.82B) | ($0.60B) | ($0.41B) | $1.34B |
| Total Liab & Equity(computed) | $2.35B | $1.60B | $0.71B | $0.81B | $2.44B |
| Debt Summary | |||||
| Total Debt | $1.06B | $1.20B | $0.87B | $0.04B | $0.82B |
| Net Debt | $0.75B | $0.36B | $0.82B | $0.02B | $0.70B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Core Scientific, Inc.
关于Core Scientific, Inc.（CORZ）资产负债表
Core Scientific, Inc.总资产$2.35B，现金及短期投资$0.31B，总负债$3.31B，总债务$1.06B，股东权益($0.96B)。
常见问题
CORZ · 4 问Core Scientific, Inc.总债务$1.06B，净债务$0.75B。
CORZ total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10